{
  "docId": "019de070-8dac-72dd-8b30-47dcdd26ea78",
  "docSlug": "14b2a339e11f22ed5b817a794c035302",
  "documentTitle": "Chimerix | Mergers and Acquisitions Presentation Deck | 26 slides",
  "authorId": "chimerix",
  "authorName": "Chimerix",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 26,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "problem_statement",
  "function": "diagnose_problem",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The chart is a bubble plot showing median overall survival across various trials, with bubble size representing patient count.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-8dac-72dd-8b30-47dcdd26ea78/5",
  "deckHref": "/decks/019de070-8dac-72dd-8b30-47dcdd26ea78",
  "deckJsonHref": "/decks/019de070-8dac-72dd-8b30-47dcdd26ea78.json",
  "deckAnchorHref": "/decks/019de070-8dac-72dd-8b30-47dcdd26ea78#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.4,
        "x": 0.55,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Median overall survival weighted average: ~8 months in recurrent glioma post TMZ",
      "attrs": null,
      "subkind": "bubble",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "839781da-bbee-43e8-842c-8fa7df759666",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.45,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "list",
      "text": "No effective therapy: Often not possible to resect; Recurrence inevitable; Invariably lethal (~8 months mOS); Chemotherapy ineffective.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6dbd9a11-53b7-48d9-9d0d-8f99b78d2701",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.45,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "Most frequent histone mutation in glioma: Frequent (>50%) in younger patients with midline brain tumors; Classified as grade IV by WHO; Mutation routinely identified via IHC or NGS.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d47d016-e9b6-4142-a478-cfa682b3cc90",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "1. Response Assessment in Neuro-Oncology-High Grade Glioma. 2. Data collected from 17 literature sources since 2010...",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bd5abc17-dad1-4fb4-8d3c-ad4f5fb0ee7b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Recurrent H3 K27M+ recurrent glioma, a devastating disease where single agent responses are rare and lack durability",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e733af7-2792-4161-beeb-1f6ef9a87fac",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "dbc28779-9acd-4e02-a680-bcca09a92173",
      "evidence": "The slide presents a clear problem statement about a devastating disease with no effective therapy.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}